🇺🇸 FDA
Pipeline program

bendamustine

C18083/3064/NL/MN

Phase 3 small_molecule completed

Quick answer

bendamustine for Non-Hodgkin's Lymphoma is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Non-Hodgkin's Lymphoma
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials